HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Liver Resection Promotes Long-Term Survival

By HospiMedica International staff writers
Posted on 09 Mar 2015
Print article
A new study shows that in situ split (ISS) liver resection can provide long-term survival for patients with advanced liver malignancies.

Researchers at University Hospital Regensburg (Germany) conducted a study that retrospectively analyzed 16 patients who underwent ISS liver resection between 2007 and 2014. The procedure involves a novel method to induce rapid hypertrophy of the contra-lateral liver lobe, and is intended for patients at risk of postoperative liver failure due to an insufficient amount of liver tissue remaining after the resection. Two patients were lost in early postoperative phase (90 days), and one was lost during follow-up.

Of the remaining 13 patients with a follow-up period of more than 3 months, seven suffered from colorectal liver metastases (CRLM), and six from various other liver malignancies (non-CRLM). The ISS procedure resulted in a median increase of 86.3% of the left lateral liver lobe after a median time period of nine days. The median disease-free survival (DFS) time was 14.6 months, and the median overall survival was 41.7 months (reduced to 26.4 months when including 90-days mortality). The three-year survival rate was 64.3% for the CRLM and 50% for the non-CRLM patients. The study was published in the February 2015 issue of Langenbeck's Archives of Surgery.

“We retrospectively analyzed our patients treated with ISS liver resection at the department of surgery of the University of Regensburg, the first center worldwide to perform ISS,” concluded lead author Sven Lang, MD, and colleagues. “ISS liver resection can provide long-term survival of selected patients with advanced liver malignancies that otherwise are not eligible for liver resection due to insufficient liver remnant.”

ISS, also known as associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) combines portal vein ligation and complete parenchymal transaction, splitting the lobe along the right side of the falciform ligament. After a median of nine days, the segments increase by about 75%, allowing for the subsequent hepatectomy.

Related Links:

University Hospital Regensburg


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Autoclavable Camera System
Precision AC

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more